ENO2
Gamma-enolase
Also known as: ENOG_HUMAN, NSE
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P09104
- Gene
- ENO2
- Ensembl
- ENSG00000111674
- Chromosome
- 12
- Canonical length
- 434 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes one of the three enolase isoenzymes found in mammals. This isoenzyme, a homodimer, is found in mature neurons and cells of neuronal origin. A switch from alpha enolase to gamma enolase occurs in neural tissue during development in rats and primates. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
434 residues, UniProt reviewed canonical sequence.
>P09104|ENO2
1 MSIEKIWARE ILDSRGNPTV EVDLYTAKGL FRAAVPSGAS TGIYEALELR DGDKQRYLGK
61 GVLKAVDHIN STIAPALISS GLSVVEQEKL DNLMLELDGT ENKSKFGANA ILGVSLAVCK
121 AGAAERELPL YRHIAQLAGN SDLILPVPAF NVINGGSHAG NKLAMQEFMI LPVGAESFRD
181 AMRLGAEVYH TLKGVIKDKY GKDATNVGDE GGFAPNILEN SEALELVKEA IDKAGYTEKI
241 VIGMDVAASE FYRDGKYDLD FKSPTDPSRY ITGDQLGALY QDFVRDYPVV SIEDPFDQDD
301 WAAWSKFTAN VGIQIVGDDL TVTNPKRIER AVEEKACNCL LLKVNQIGSV TEAIQACKLA
361 QENGWGVMVS HRSGETEDTF IADLVVGLCT GQIKTGAPCR SERLAKYNQL MRIEEELGDE
421 ARFAGHNFRN PSVLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ENO2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.19
- Highest tissue expression
- 1,573 nTPM
Expression across tissuesHPA
Tissue
- retina: 1,573 nTPM
- cerebellum: 858 nTPM
- cerebral cortex: 527 nTPM
- basal ganglia: 336 nTPM
- hypothalamus: 278 nTPM
- amygdala: 218 nTPM
Single-cell type
- rod photoreceptor cells: 469 nCPM
- cone photoreceptor cells: 360 nCPM
- retinal horizontal cells: 198 nCPM
- brain excitatory neurons: 166 nCPM
- retinal bipolar cells: 164 nCPM
- other brain neurons: 132 nCPM
Immune cell
- memory CD4 T-cell: 13 nTPM
- MAIT T-cell: 11 nTPM
- memory CD8 T-cell: 11 nTPM
- gdT-cell: 9.9 nTPM
- naive CD8 T-cell: 8.6 nTPM
- naive CD4 T-cell: 8.2 nTPM
Brain region
- cerebral cortex: 763 nTPM
- white matter: 564 nTPM
- hypothalamus: 553 nTPM
- cerebellum: 547 nTPM
- pons: 544 nTPM
- medulla oblongata: 525 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ENO2.
Disease | ImmuneIEDB
Conditions an epitope on ENO2 was assayed in.
- multiple sclerosis B cell
- rheumatoid arthritis B cell
ReferencesPubMed · IEDB
Publications for ENO2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients.
2000 · Invest Ophthalmol Vis Sci · RCR 2.7 · 96 citations - Identification of Autoantibodies for α and γ-Enolase in Serum from a Patient with Melanoma.
2011 · Jpn Clin Med · RCR 0 · 2 citations
Reference: B cellIEDB
3 publications
- Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
2009 · Ann Rheum Dis · RCR 4.2 · 156 citations - High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.
2016 · Mol Cell Proteomics · RCR 2.5 · 66 citations - Peptides of neuron specific enolase as potential ASD biomarkers: From discovery to epitope mapping.
2020 · Brain Behav Immun · RCR 1.4 · 25 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.47
- gnomAD pLI
- 0.38
- gnomAD missense Z
- 1.81
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- canonical glycolysis
- gluconeogenesis
- glycolytic process
- response to estradiol
- response to xenobiotic stimulus
Molecular functions
- enzyme binding
- identical protein binding
- magnesium ion binding
- phosphopyruvate hydratase activity
- protein-containing complex binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ENO2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ENO2 as an antibody target. Whether an autoantibody or antibody against ENO2 could matter depends on whether native ENO2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ENO2 is annotated at the cell surface, where native ENO2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ENO2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...